Acino's manufacturing plant in Ukraine—Pharma Start—has successfully been certified according to the Good Manufacturing Practice of the European Union (EU GMP).
Acino is delighted to announce that it will begin commercial operations in Turkey.
As the era of blockbuster drugs comes to an end, pharma is moving towards drugs that are increasingly complex and made for small patient populations, creating opportunities and challenges for contract development and manufacturing organisations (CDMOs).
Acino is proud to have been recognized as the Best Pharmaceutical Company 2019 by the Armenia - Artsakh - Diaspora association in Armenia for our contribution to the development of the country’s pharmaceutical industry, our high-quality medicines and successful cooperation with the Armenian healthcare community.
The partnership will see both companies provide respective services in the creation of high-quality pharmaceutical products.
Acino will acquire approximately 30 products from Takeda’s primary care portfolio in selected countries in the Middle East and Africa, and in Ukraine; subject to conditions.
Partnering with the Iraqi Hypertension Society (IHS), we support our commity in Iraq on World Heart Day.
Acino is proud to announce a partnership with the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences.